3 Things Investors Need to Know About Recursion Pharmaceuticals

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...
Nasdaq

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio SALT LAKE CITY, Nov. 09, 2023 ...